Literature DB >> 29503446

Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy.

Shuping Zhang1, Meng Wu1, Fang Wang2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29503446      PMCID： PMC6203794          DOI： 10.1038/cmi.2018.170

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  12 in total

1.  CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway.

Authors:  Zhubo Chen; Yanmei Han; Yan Gu; Yanfang Liu; Zhengping Jiang; Minghui Zhang; Xuetao Cao
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

Review 2.  Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.

Authors:  Haiping Wang; Fabien Franco; Ping-Chih Ho
Journal:  Trends Cancer       Date:  2017-07-14

3.  Gene expression profiling of CD8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8+ Treg cell production.

Authors:  Meng Wu; Jianfang Lou; Shuping Zhang; Xian Chen; Lei Huang; Ruihong Sun; Peijun Huang; Shiyang Pan; Fang Wang
Journal:  Cell Prolif       Date:  2016-09-19       Impact factor: 6.831

4.  Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells.

Authors:  Keri Csencsits; Sherri Chan Wood; Guanyi Lu; D Keith Bishop
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

5.  Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.

Authors:  Quanrongzi Wang; Tongfu Yu; Yifeng Yuan; Haiwen Zhuang; Zhaojing Wang; Xisheng Liu; Min Feng
Journal:  J Surg Oncol       Date:  2012-07-25       Impact factor: 3.454

6.  Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.

Authors:  Cheng Chen; Dongdong Chen; Yongkui Zhang; Zhijun Chen; Wangyu Zhu; Binjie Zhang; Zhaoye Wang; Hanbo Le
Journal:  Int Immunopharmacol       Date:  2013-12-15       Impact factor: 4.932

7.  Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Authors:  N Chaput; S Louafi; A Bardier; F Charlotte; J-C Vaillant; F Ménégaux; M Rosenzwajg; F Lemoine; D Klatzmann; J Taieb
Journal:  Gut       Date:  2008-11-20       Impact factor: 23.059

8.  CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Authors:  Yukiko Kiniwa; Yoshihiro Miyahara; Helen Y Wang; Weiyi Peng; Guangyong Peng; Thomas M Wheeler; Timothy C Thompson; Lloyd J Old; Rong-Fu Wang
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

9.  Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.

Authors:  Shuping Zhang; Xing Ke; Suyun Zeng; Meng Wu; Jianfang Lou; Lei Wu; Peijun Huang; Lei Huang; Fang Wang; Shiyang Pan
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

10.  TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.

Authors:  Meng Wu; Xian Chen; Jianfang Lou; Shuping Zhang; Xiaojie Zhang; Lei Huang; Ruihong Sun; Peijun Huang; Fang Wang; Shiyang Pan
Journal:  Oncotarget       Date:  2016-07-12
View more
  18 in total

1.  Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients.

Authors:  Alhasan Alsalman; Mohammad A Al-Mterin; Khaled Murshed; Ferial Alloush; Samia T Al-Shouli; Salman M Toor; Eyad Elkord
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

2.  Suppression of Chlamydial Pathogenicity by Nonspecific CD8+ T Lymphocytes.

Authors:  Lingxiang Xie; Conghui He; Jianlin Chen; Lingli Tang; Zhiguang Zhou; Guangming Zhong
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

3.  Impact of Early ARV Initiation on Relative Proportions of Effector and Regulatory CD8 T Cell in Mesenteric Lymph Nodes and Peripheral Blood During Acute SIV Infection of Rhesus Macaques.

Authors:  Alexis Yero; Omar Farnos; Julien Clain; Ouafa Zghidi-Abouzid; Henintsoa Rabezanahary; Gina Racine; Jérôme Estaquier; Mohammad-Ali Jenabian
Journal:  J Virol       Date:  2022-03-21       Impact factor: 5.103

Review 4.  The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer.

Authors:  Nanna Jørgensen; Gry Persson; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

5.  Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice.

Authors:  Ying Wu; Yu-Mei Chang; Anneliese J Stell; Simon L Priestnall; Eshita Sharma; Michelle R Goulart; John Gribben; Dong Xia; Oliver A Garden
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

6.  Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma.

Authors:  Nicholas Frazzette; Alireza Khodadadi-Jamayran; Nicole Doudican; Alexis Santana; Diane Felsen; Anna C Pavlick; Aristotelis Tsirigos; John A Carucci
Journal:  NPJ Precis Oncol       Date:  2020-06-03

Review 7.  A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity.

Authors:  Jürgen Geisler; Joel Touma; Afsar Rahbar; Cecilia Söderberg-Nauclér; Katja Vetvik
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

8.  Technical advances in NK cell-based cellular immunotherapy.

Authors:  Fang Fang; Wei Wang; Minhua Chen; Zhigang Tian; Weihua Xiao
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

9.  Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.

Authors:  Jing Liu; Yuan Hu; Qie Guo; Xin Yu; Liwei Shao; Cai Zhang
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

10.  Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactions.

Authors:  Erez Nissim Baruch; Rona Ortenberg; Camila Avivi; Liat Anafi; Daniela Dick-Necula; Chani Stossel; Yonatan Moshkovits; Orit Itzhaki; Michal Judith Besser; Jacob Schachter; Iris Barshack; Gal Markel
Journal:  Oncoimmunology       Date:  2020-03-25       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.